ELEM
1 known investors
Find your way into ELEM
725 people in our graph share verified history with the ELEM team — schools, employers, funds. One of them is your warm intro.
David Naultunlockedknows Guillaume Houzeaux · together at Concordia University (overlapped)
knows the team · via Imperial College London
×2knows the team · via Concordia University
×2knows the team · via University of Buenos Aires
×2knows the team · via Université de Montréal
×4knows the team · via Universitat Politècnica de Catalunya
ELEM develops healthcare digital twins using biosimulation technology to enable pharmaceutical and medical device companies to test and predict treatment outcomes before clinical trials. The company combines biomedical science, mechanistic modeling, AI, and high-performance computing to replicate human physiology for safer, more efficient drug and device development.
Founders & leadership
CM
Christopher MortoninFounderChristopher Morton holds degrees in Aeronautical Engineering from Imperial College and Business Studies from Hult IBS, and brings over two decades of experience in emerging technology ventures across mechanical industries including aerospace, automotive, and energy sectors. He transitioned to health technology five years ago and now leads ELEM, which develops healthcare digital twins using biosimulation for pharmaceutical and medical device testing, following executive roles at Atos and Sogeti HighTech, and founding Samtech UK prior to its acquisition by Siemens.
MV
Mariano VázquezinCo-FounderMariano Vázquez is a computational mechanics researcher at the Barcelona Supercomputing Center, where he co-led the development of ALYA, a large-scale computational mechanics code for multi-physics simulations on supercomputers, and now serves as co-founder of ELEM Biotech, which applies biosimulation technology to drug and device development.
GH
Guillaume HouzeauxinCo-FounderGuillaume Houzeaux holds a PhD in Computational Fluid Dynamics from Universitat Politècnica de Catalunya and has worked as a senior researcher in high-performance computing and scientific computing. He is co-founder of ELEM, a healthcare company developing biosimulation technology for pharmaceutical and medical device testing.
Investors · 1
Frequently asked questions
- What does ELEM do?
- ELEM develops healthcare digital twins using biosimulation technology to enable pharmaceutical and medical device companies to test and predict treatment outcomes before clinical trials. The company combines biomedical science, mechanistic modeling, AI, and high-performance computing to replicate human physiology for safer, more efficient drug and device development.
- Who founded ELEM?
- ELEM was founded by Christopher Morton, Mariano Vázquez, Guillaume Houzeaux.
- Who are ELEM's investors?
- ELEM's investors include Capital Cell.